Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632761 · ClinicalTrials.gov registry record · NA
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
A NA study of Anemia, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT01632761 is a NA study of Anemia that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 2,000 participants, above the 400-participant average among 72 other Anemia trials with a reported enrollment target (400% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01632761, a NA study of Anemia, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The VITamin D and OmegaA-3 TriaL (VITAL; NCT01169259) is a randomized clinical trial in 20,000 U.S. men and women studying whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among VITAL participants and will study whether vitamin D or fish oil: (A) in the overall VITAL cohort, reduces the number of persons diagnosed with anemia and (B) in a subcohort of 900 participants seen in Boston, effects long-term changes of the proteins in blood in both anemic and non-anemic individuals who provide blood samples at the start of the study and again 2 years later.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Fish oil placebo
- DRUG omega-3 fatty acids (fish oil)
- DIETARY_SUPPLEMENT Vitamin D3 .
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2012-11 |
| Est. Completion | 2025-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01632761
The ClinicalTrials.gov registry entry for NCT01632761 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 400-participant average among 72 other Anemia trials with a reported enrollment target (400% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 4 interventions - of which Vitamin D3 placebo is the first listed.
NCT01632761 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01632761 about?
NCT01632761 is a clinical study titled "Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia". The VITamin D and OmegaA-3 TriaL (VITAL; NCT01169259) is a randomized clinical trial in 20,000 U.S. men and women studying whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stro...
What is the current status of trial NCT01632761?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2012-11. Estimated completion is 2025-12-28.
What conditions does trial NCT01632761 study?
This clinical trial studies the following conditions: Anemia.
What interventions are being tested in trial NCT01632761?
The interventions under investigation include: Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), omega-3 fatty acids (fish oil) (DRUG), Vitamin D3 . (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01632761?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01632761 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
RECRUITING · NA
-
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
RECRUITING · NA
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
ACTIVE NOT RECRUITING · NA
-
Placental Transfusion in Term Infants: A Pilot Study
COMPLETED · NA
-
Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.